Department of Orthopaedic Surgery, Washington University School of Medicine, 660 South Euclid Avenue, Campus Box 8233, St. Louis, Missouri.
Shriners Hospitals for Children-St. Louis, St. Louis, Missouri.
J Orthop Res. 2020 Jan;38(1):117-127. doi: 10.1002/jor.24406. Epub 2019 Jul 26.
Adipose-derived stem cells (ASCs) have the potential to enhance tendon repair via paracrine regulation of the inflammatory response to injury. Extracellular vesicles (EVs), which are secreted by ASCs, have shown promise in mediating this process. This study was designed to evaluate the effect of ASC EVs on early tendon healing using a mouse Achilles tendon injury and repair model. EVs were isolated from the conditioned medium of naïve and interferonγ-primed ASCs and applied to the repair site via a collagen sheet. Tendon healing was assessed in nuclear factor-κB (NF-κB)-luciferase reporter mice up to 7 days after suture repair. As anticipated, repair site NF-κB activity increased greater than twofold following tendon repair. Treatment with EVs from primed but not naïve ASCs effectively suppressed the response. Accordingly, the pro-inflammatory genes Il1b and Ifng were both dramatically increased in repaired tendons, while primed, but not naïve ASC EVs attenuated the response. Compared with control repairs, primed ASC EVs further reduced the rate of post-repair tendon gap formation and rupture and facilitated collagen formation at the injury site. Additional experiments demonstrated that EVs target macrophages and that primed ASC EVs were most effective in blocking macrophage NF-κB activity. Collectively, the findings of this study demonstrate that primed ASC EVs, similar to ASCs, attenuate the early tendon inflammatory response after injury via modulation of the macrophage inflammatory response. Statement of clinical significance: These findings introduce a new cell-free therapy, derived from stem cells, for tendon repair with the potential for improved therapeutic efficacy and safety. © 2019 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 38:117-127, 2020.
脂肪来源的干细胞 (ASCs) 具有通过旁分泌调节损伤后的炎症反应来增强肌腱修复的潜力。ASCs 分泌的细胞外囊泡 (EVs) 在介导这一过程中显示出了潜力。本研究旨在使用小鼠跟腱损伤和修复模型评估 ASC EV 对早期肌腱愈合的影响。EVs 从未成熟和干扰素γ-预处理的 ASCs 的条件培养基中分离出来,并通过胶原片应用于修复部位。在缝合修复后 7 天内,在核因子-κB (NF-κB) -荧光素酶报告小鼠中评估肌腱愈合情况。正如预期的那样,肌腱修复后修复部位 NF-κB 活性增加了两倍以上。用预处理而不是未成熟的 ASC EV 处理可有效抑制反应。相应地,修复肌腱中 Il1b 和 Ifng 这两个促炎基因均显著增加,而预处理但未成熟的 ASC EV 则减弱了该反应。与对照修复相比,预处理 ASC EV 进一步降低了修复后肌腱间隙形成和断裂的速度,并促进了损伤部位的胶原形成。进一步的实验表明,EVs 靶向巨噬细胞,预处理 ASC EV 最有效地阻断巨噬细胞 NF-κB 活性。总的来说,本研究的结果表明,预处理的 ASC EV 与 ASCs 相似,通过调节巨噬细胞炎症反应,减轻损伤后早期肌腱的炎症反应。临床意义的声明:这些发现为肌腱修复引入了一种新的无细胞疗法,源自干细胞,具有改善治疗效果和安全性的潜力。2019 年骨科研究协会。威利期刊公司出版。J Orthop Res 38:117-127, 2020.